In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Papers published in 2025 in scientific journals
Most highly cited researchers in the world in 2025
Issued patents
Start-ups founded on Gladstone-licensed technology since 2015
Raised and realized by Gladstone start-ups, based on Gladstone technology
Translational research support negotiated and executed, 2020 – 2025



Gladstone is located in San Francisco, surrounded by three world-class universities and at the epicenter of a thriving biotech and venture capital ecosystem. Our streamlined leadership structure and unique culture allow us to pursue the boldest scientific ideas as urgently as we can, to ultimately help as many patients as possible.





Gladstonians
PhD & Postdoc Students
Scientists
Research Administration
Nobel Prize Winners
Members of the National Academy of Medicine




Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Inspired by bacterial biology, the Gladstone-developed “Detectron” opens up new possibilities for disease research and potentially treatments.
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsDiscoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreYour gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now